Vanda Pharmaceuticals Inc. Share Price

Vanda Pharmaceuticals Inc. Share Price

NASDAQ: VNDA | Micro Cap
$3.79
-$0.26 (-6.43%) Last updated on 31 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Vanda Pharmaceuticals Inc. Stock Performance

Open
$4.00
Prev. Close
$4.04
Circuit Range
N/A
Day Range
$3.75 - $4.10
Year Range
$3.75 - $9.92
Volume
1,38,272
Average Traded
$3.86

Vanda Pharmaceuticals Inc. Share Price Today

As of 31 October 2026, Vanda Pharmaceuticals Inc.'s share price is $3.79. The stock opened at $4.00, compared to its previous close of $4.04. During today's trading session, Vanda Pharmaceuticals Inc.'s share price traded between $3.75 and $4.10, with an average price of $3.92. Over the past 52 weeks, the stock has recorded a high of $9.92 and a low of $3.75. In terms of performance, Vanda Pharmaceuticals Inc.'s share price has declined by 46.58% over the last six months and is down 12.59% on a year-on-year basis.

Vanda Pharmaceuticals Inc. Share Price Chart

Line chart of the Vanda Pharmaceuticals Inc. price trend over the selected period. The price fell overall, ranging from 3.75 to 4.09, ending at 3.79.
$3.75$4.10
L
Show Current Price
H

Vanda Pharmaceuticals Inc. Stock Fundamentals & Key Indicators

Market Cap
$223.05M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-4.54
Revenue (TTM)
$216.11B
Return On Equity (TTM)
-137.51%
Profit Margin
-102.02%
Debt to Equity
0.01
Quarterly Earnings Growth YoY
-176.72%

Vanda Pharmaceuticals Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$56.26$57.22$51.72$50.53
Net Profit-$22.59-$141.19-$48.57-$62.51
Net Profit Margin-40.15%-246.75%-93.91%-123.71%
Income ChangeN/A-525.01%65.60%-28.70%

Vanda Pharmaceuticals Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$254.38$192.64$198.77$216.11
Net Profit$6.28$2.51-$18.90-$220.47
Net Profit Margin2.47%1.30%-9.51%-102.02%
Income ChangeN/A-60.03%-852.99%-1066.51%

About Vanda Pharmaceuticals Inc.

Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include ASO Molecules, VQW-765, Tradipitant, and VTR-297. The maximum of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.

Vanda Pharmaceuticals Inc. Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Oct 2026
$4.85
$3.78
-23.01%
Sep 2026
$5.42
$4.91
-9.74%
Aug 2026
$5.03
$5.44
+6.77%
Jul 2026
$6.08
$5.09
-16.61%
Jun 2026
$6.35
$6.11
-5.34%
May 2026
$7.11
$6.46
-8.89%
Apr 2026
$7.06
$7.08
+2.53%
Mar 2026
$8.71
$6.91
-22.49%
Feb 2026
$7.65
$8.91
+18.08%
Jan 2026
$8.69
$7.55
-14.30%
Dec 2025
$5.29
$8.81
+64.21%
Nov 2025
$4.43
$5.37
+23.90%

VNDA Share Price FAQs